Contact Us

Thank you for your interest. We have completed the 013 Open Label trial enrollment at this time.

For information on the SER-109 Expanded Access Program, please visit https://www.serestherapeutics.com/patients-and-physicians/.




The open-label clinical study of SER-109 is being offered at locations across the United States and Canada. Find a study site near you by entering your ZIP code below.